HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Penna Selected Research

Trinitrobenzenesulfonic Acid

4/2011Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Penna Research Topics

Disease

10Inflammation (Inflammations)
10/2021 - 12/2002
7Autoimmune Diseases (Autoimmune Disease)
05/2009 - 02/2003
5Neoplasms (Cancer)
11/2021 - 01/2006
5Prostatitis
09/2009 - 12/2006
3Colitis
08/2015 - 06/2010
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2010 - 02/2007
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2004 - 02/2003
2Breast Neoplasms (Breast Cancer)
11/2021 - 03/2007
2Infections
01/2021 - 02/2014
2Pelvic Pain
02/2007 - 12/2006
1COVID-19
01/2022
1Paralysis (Palsy)
11/2021
1Osteosarcoma (Osteogenic Sarcoma)
01/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Insulin Resistance
12/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2016
1Celiac Disease (Celiac Sprue)
11/2015
1Genetic Predisposition to Disease (Genetic Predisposition)
09/2015
1Septic Shock (Toxic Shock Syndrome)
08/2015
1Necrosis
04/2011
1Hypercalcemia (Milk Alkali Syndrome)
06/2010
1Ulcerative Colitis
06/2010
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2010
1Crohn Disease (Crohn's Disease)
06/2010
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2007
1Osteoporosis
07/2007
1Secondary Hyperparathyroidism
07/2007
1Colonic Neoplasms (Colon Cancer)
03/2007
1Prostatic Neoplasms (Prostate Cancer)
03/2007
1Carcinogenesis
03/2007
1Neoplasm Metastasis (Metastasis)
01/2006
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2006
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2002

Drug/Important Bio-Agent (IBA)

10Calcitriol Receptors (Calcitriol Receptor)IBA
06/2010 - 02/2003
4LigandsIBA
08/2004 - 12/2002
3CytokinesIBA
09/2009 - 02/2007
3BXL628IBA
04/2009 - 12/2006
3ChemokinesIBA
02/2007 - 12/2002
2Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2007
2Peptides (Polypeptides)IBA
01/2021 - 08/2007
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2011 - 06/2010
2Dextrans (Dextran)FDA Link
04/2011 - 06/2010
21,25-dihydroxyvitamin DIBA
06/2010 - 03/2007
2Interleukin-12 (IL 12)IBA
09/2009 - 06/2003
2Interleukin-8 (Interleukin 8)IBA
04/2009 - 02/2007
2NF-kappa B (NF-kB)IBA
04/2009 - 08/2004
2Vitamin DFDA LinkGeneric
08/2008 - 08/2004
2Calcitriol (Calcijex)FDA LinkGeneric
03/2007 - 01/2006
1ChitinasesIBA
11/2021
1Trastuzumab (Herceptin)FDA Link
11/2021
1LipopolysaccharidesIBA
10/2021
1viral interferon regulatory factorsIBA
10/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2021
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Choline (Choline Chloride)IBA
12/2019
1Methionine (L-Methionine)FDA Link
12/2019
1Monoclonal AntibodiesIBA
01/2016
1Cetuximab (Erbitux)FDA Link
01/2016
1Transaminases (Aminotransferases)IBA
11/2015
1AntigensIBA
09/2015
1Protein Isoforms (Isoforms)IBA
08/2015
1APTIBA
02/2014
1obeticholic acidIBA
04/2011
1Trinitrobenzenesulfonic AcidIBA
04/2011
1AutoantigensIBA
09/2009
1Interleukin-23 (Interleukin 23)IBA
09/2009
1Hormones (Hormone)IBA
05/2009
1Interleukin-6 (Interleukin 6)IBA
04/2009
1rho-Associated KinasesIBA
04/2009
1Biological ProductsIBA
01/2009
1ProstateinIBA
08/2007
1ReninIBA
03/2007
1Messenger RNA (mRNA)IBA
03/2007
1SteroidsIBA
12/2006
1Carrier Proteins (Binding Protein)IBA
12/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2006
1Pharmaceutical PreparationsIBA
01/2006
1Epirubicin (Ellence)FDA LinkGeneric
01/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2006
1NF-KappaB Inhibitor alphaIBA
08/2004
1Chemokine CCL22IBA
09/2002

Therapy/Procedure

1Therapeutics
01/2021
1Rectal Administration
06/2010
1Immunotherapy
01/2006